Biogen Bets Big On $2 Billion Expansion To Boost US Drug Manufacturing

Biogen Inc. BIIB said on Monday that it plans to invest an additional $2 billion in its existing manufacturing footprint in North Carolina’s Research Triangle Park (RTP).Biogen has invested approximately $10 billion in its North Carolina manufacturing footprint to date, including more than $3 billion in recent years, and this upcoming investment will fuel the continued advancement of Biogen’s late-stage clinical pipeline.In the next few years, Biogen plans to continue investing in multiple modalities and fa ...